The new Gospell GR-221 receiver is using CLM Micro’s DRM1000 module. Both made their debut at IBC 2023. (Photo courtesy DRM, via Instagram) During the IBC 2023 DRM Showcase Event, CML Microcircuits ...
Lindsay A. Rein, MD, reviews exciting data presented at this year’s ASH meeting, focusing on chronic myeloid leukemia (CML) and the recent approval of asciminib, a novel agent for first-, second-, and ...
Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results